U.S. Aerospace & Defense Stock News

NasdaqGS:VFS
NasdaqGS:VFSAuto

Is VinFast Auto (VFS) Now Priced Attractively After Prolonged Share Price Weakness

If you are wondering whether VinFast Auto's share price reflects its true worth, you are not alone and the numbers raise some clear valuation questions. The stock last closed at US$3.22, with returns of a 0.9% decline over 7 days, a 2.4% decline over 30 days, a 4.7% decline year to date and a 9.3% decline over the past year, while the 3-year return sits at a 68.3% decline. Recent coverage around VinFast Auto has focused on its position in the electric vehicle space, its ongoing capital...
NYSE:GDDY
NYSE:GDDYIT

How AI Agent Verification, MuleSoft Integration and Buybacks At GoDaddy (GDDY) Has Changed Its Investment Story

In February 2026, GoDaddy reported fourth-quarter 2025 revenue of US$1,273.9 million and net income of US$245.1 million, alongside continued share repurchases and an AI agent-identity integration with Salesforce’s MuleSoft. Beyond the headline numbers, GoDaddy’s Agent Name Service move into AI agent verification extends its traditional DNS expertise into a new layer of digital trust infrastructure. We’ll now examine how GoDaddy’s strong quarterly earnings, ongoing buybacks, and MuleSoft AI...
NYSE:BAP
NYSE:BAPBanks

Does Credicorp’s Dividend Policy Revamp and Governance Shift Reshape Its Capital Allocation Narrative (BAP)?

In recent weeks, Credicorp Ltd.’s board has approved several balance sheet moves, including transferring S/5,637.7 million and S/1,778.8 million from retained earnings to reserves, authorizing an additional S/875.9 million dividend from reserves, and updating its dividend policy at the February 26, 2026 meeting. Alongside these capital decisions, upcoming board retirements and proposed new director appointments at the March 31, 2026 online AGM signal a shift in Credicorp’s governance that...
NYSE:KRMN
NYSE:KRMNAerospace & Defense

Why Karman Holdings (KRMN) Is Up 14.5% After Raising Guidance Despite an Earnings Miss – And What's Next

Karman Holdings recently reported past-quarter results that missed earnings expectations but raised its full-year revenue and EBITDA guidance, highlighting its role in missile and hypersonic defense systems aligned with Pentagon priorities. This combination of upgraded outlook and emphasis on defense technologies positioned at the heart of U.S. security planning has sharpened investor focus on Karman’s longer-term potential. Next, we’ll examine how Karman’s upgraded full-year guidance might...
NasdaqGS:TXRH
NasdaqGS:TXRHHospitality

A Look At Texas Roadhouse (TXRH) Valuation After Mixed 2025 Results And Expansion Plans

Texas Roadhouse (TXRH) is back in the spotlight after its 2025 Form 10-K and fourth quarter report showed higher revenue but lower net income, alongside continued expansion plans and ongoing dividends and buybacks. See our latest analysis for Texas Roadhouse. While the latest quarterly report and dividend decision are in focus, Texas Roadhouse’s share price tells a quieter story. A 6.04% 90-day share price return contrasts with a much stronger 80.70% three-year total shareholder return,...
NasdaqGS:CART
NasdaqGS:CARTConsumer Retailing

Is It Time To Reassess Instacart (CART) After Mixed Recent Share Price Performance

If you are wondering whether Maplebear at around US$37.84 is pricing in too much optimism or not enough, you are not alone. This article is built to help you make sense of that. The stock has returned 4.6% over the last 7 days and 1.8% over the last 30 days, although the year to date return of a 13.8% decline and a 2.7% decline over the past year show a mixed picture. Recent coverage has focused on Maplebear’s position in online grocery and same day delivery, as investors assess how its...
NYSE:VMC
NYSE:VMCBasic Materials

Assessing Vulcan Materials (VMC) Valuation After Mixed Q4 Results And Confident 2026 Growth Outlook

Vulcan Materials (VMC) is back in focus after a mixed fourth quarter, with revenue and earnings below forecasts, but full year 2025 results showing higher adjusted EBITDA, stronger operating cash flow, and fresh 2026 guidance. See our latest analysis for Vulcan Materials. At a share price of $306.20, Vulcan Materials has seen a 5.64% 90 day share price return and a 28.65% 1 year total shareholder return. This suggests momentum has been positive despite the recent earnings miss and ongoing...
NYSE:GBX
NYSE:GBXMachinery

Will Greenbrier's (GBX) Profit Beat Despite Revenue Drop Reshape Its Efficiency-Driven Investment Narrative?

In its recent earnings report, Greenbrier Companies posted a 19.4% year-on-year revenue decline but still exceeded analyst expectations on revenue, earnings per share, and adjusted operating income. This mix of weaker top-line demand and stronger-than-expected profitability highlights how cost control and efficiency efforts are influencing Greenbrier’s financial profile. Next, we’ll examine how this earnings beat, driven by stronger profitability despite lower revenue, may influence...
NYSE:DRD
NYSE:DRDMetals and Mining

DRDGOLD’s Vision 2028 Work And What It May Mean For Valuation

DRDGOLD is progressing its Vision 2028 initiative, focused on infrastructure upgrades and operational improvements across its tailings operations. The company is moving ahead with plans to link processing plants and restart deposition at key tailings storage facilities. These developments are intended to support longer term operating plans and more efficient use of existing assets. For investors watching NYSE:DRD, the Vision 2028 work sits against a share price of $38.32 and multi year...
NYSE:SWK
NYSE:SWKMachinery

Assessing Stanley Black & Decker (SWK) Valuation As New Britain Plant Closure Ends 180 Years Of Production

Stanley Black & Decker (SWK) is closing its historic New Britain, Connecticut tape measure plant, cutting about 300 jobs as demand for single sided tape measures declines in favor of newer measuring technologies. See our latest analysis for Stanley Black & Decker. The plant closure headlines come after a period where the share price has been relatively resilient, with a 30 day share price return of 6.84% and a 90 day share price return of 17.97%. However, the 5 year total shareholder return...
NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

A Look At Expedia Group (EXPE) Valuation After Q4 Beat And New PredictHQ Partnership

Expedia Group (EXPE) is back in focus after solid Q4 revenue and earnings beats, followed by a new PredictHQ partnership that ties event driven demand forecasts directly into its platform for lodging partners. See our latest analysis for Expedia Group. Even with the Q4 beat and new PredictHQ partnership in focus, Expedia Group’s recent share price performance has been mixed. The 7 day share price return is 13.12%, the 30 day share price return is 19.48%, and the year to date share price...
NasdaqCM:RR
NasdaqCM:RRMachinery

Richtech Robotics Lawsuits Put Microsoft Ties And Investor Trust In Focus

Multiple law firms have filed class action lawsuits against Richtech Robotics (NasdaqCM:RR) alleging the company misled investors about its relationship with Microsoft. The suits claim Richtech described a collaborative and commercial partnership with Microsoft, while Microsoft has reportedly denied having a commercial relationship. Investors are focusing on potential disclosure issues, legal exposure, and the impact of these claims on Richtech's credibility and future capital...
NYSE:CRI
NYSE:CRILuxury

Carter's Revenue Turnaround Meets Store Closures And Product Shift Plan

Carter's (NYSE:CRI) has reported its first year over year revenue growth since 2021, supported by stronger retail sales and demand creation efforts. The company plans to close about 150 lower margin stores by 2028 while expanding higher priced product assortments for Gen Z and Millennial families. Carter's is also putting more emphasis on direct to consumer channels as it adjusts to changing shopping habits and cost pressures. Carter's shares recently closed at $34.95, with the stock down...
NasdaqGS:ITRI
NasdaqGS:ITRIElectronic

Itron Raises US$700m In Convertible Notes To Support Grid Modernisation

Itron (NasdaqGS:ITRI) has completed a $700 million offering of convertible senior notes. The offering follows the company’s fourth quarter results, which were described as robust and above expectations. The transaction adds a sizable pool of capital that can influence Itron’s balance sheet and future investment decisions. Itron focuses on technology and services that help utilities and cities manage energy, water, and smart infrastructure. For investors watching the broader push toward grid...
NYSE:YOU
NYSE:YOUSoftware

Is It Too Late To Reassess Clear Secure (YOU) After Its Recent Share Price Surge

If you are wondering whether Clear Secure's share price still lines up with its underlying worth, you are not alone. This article will walk through how the current market price compares with several valuation checks. Clear Secure's stock last closed at US$48.04, with returns of 46.8% over the past 7 days, 47.3% over 30 days, 39.7% year to date and 107.7% over the past year, plus 81.8% over 3 years. Recent news coverage has focused on Clear Secure's role in identity and security services, and...
NasdaqCM:MBIN
NasdaqCM:MBINDiversified Financial

Evaluating Merchants Bancorp (MBIN) After Morgan Stanley’s Upgraded Outlook And Earnings Momentum

Why Merchants Bancorp Is On Investors' Radar Right Now Merchants Bancorp (MBIN) is drawing fresh attention after Morgan Stanley raised its outlook. Recent research highlighted the bank's earnings profile, niche mortgage franchise, and credit quality as key parts of the story. See our latest analysis for Merchants Bancorp. At a share price of $43.36, Merchants Bancorp has seen a 4.58% 1 month share price return and a 31.35% 3 month share price return, while the 1 year total shareholder return...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

Does Rhythm Pharmaceuticals (RYTM) Share Price Reflect Its Obesity Treatment Potential Today

If you are wondering whether Rhythm Pharmaceuticals' current share price lines up with its underlying value, this breakdown will help you make sense of where it stands today. The stock recently closed at US$94.94, with returns of a 1.5% decline over 7 days, a 7.4% decline over 30 days, a 9.6% decline year to date, 81.2% over 1 year, 333.1% over 3 years and 280.4% over 5 years. Recent news coverage has focused on Rhythm Pharmaceuticals' position in obesity and rare disease treatments, which...
NYSE:CUBE
NYSE:CUBESpecialized REITs

Is CubeSmart (CUBE) Still Attractively Priced After Its Recent Share Price Climb?

If you are wondering whether CubeSmart is still reasonably priced after its recent run, you are not alone. The stock now sits at US$41.84 and raises fair questions about where value really lies. CubeSmart shares have returned 5.5% over the past week, 11.5% over the last 30 days, 18.2% year to date, 4.4% over 1 year, 0.5% over 3 years, and 39.6% over 5 years, so recent moves may be changing how investors view its risk and reward trade off. Recent company coverage has focused on CubeSmart...
NYSE:CNR
NYSE:CNROil and Gas

How Investors May Respond To Core Natural Resources (CNR) Benefiting From Coal’s Geopolitical Insulation

Following recent strikes on Iran that unsettled global energy markets, coal prices have risen as the fuel remains largely outside the immediate conflict’s reach, improving its relative appeal versus other commodities. This shift has highlighted coal’s role as a comparatively insulated energy source during geopolitical shocks, drawing fresh attention to producers such as Core Natural Resources. We’ll now examine how coal’s relative insulation from these Middle East tensions shapes Core...
NYSE:CF
NYSE:CFChemicals

CF Industries (CF) Is Up 9.3% After Strong 2025 Results And Low-Carbon Push Has The Bull Case Changed?

CF Industries Holdings reported past fourth-quarter 2025 sales of US$1,872 million and net income of US$404 million, with full-year 2025 sales of US$7.08 billion and net income of US$1.46 billion, alongside a US$76 million asset impairment and completion of a US$340 million share repurchase program covering 4,100,000 shares. At the same time, CF Industries accelerated its push into low-carbon ammonia through decarbonization projects and pilot partnerships, while executive share sales and...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Ambarella’s Q4 Beat Highlights Edge AI Progress And Valuation Gap

Ambarella reported Q4 revenue that came in ahead of expectations, supported by demand for its Edge-AI SoCs in automotive and security markets. Management highlighted solid cash reserves and a focus on product transitions and margin recovery in the coming fiscal year. The company reinforced its commitment to AI-driven applications, underscoring its role in advanced driver assistance and intelligent video security. Ambarella, listed as NasdaqGS:AMBA, is drawing attention after its latest...
NYSE:MSM
NYSE:MSMTrade Distributors

A Look At MSC Industrial Direct (MSM) Valuation After CEO Transition And Cautious Earnings Outlook

MSC Industrial Direct (MSM) is back in focus after announcing that President and COO Martina McIsaac will step into the CEO role on January 1, 2026, alongside fresh board changes and recent earnings. See our latest analysis for MSC Industrial Direct. Those leadership updates and the cautious earnings outlook come after a strong run in the shares, with a 30 day share price return of 11.55% and a 1 year total shareholder return of 25.18%, suggesting momentum has been building rather than...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Is Syndax Pharmaceuticals (SNDX) Pricing Reflect Pipeline Progress Or Stretching Recent Share Gains

Curious whether Syndax Pharmaceuticals' share price really matches what the business could be worth? This article walks you through the key signals that matter before you make up your mind. With the stock at US$22.14 and returns of 11.3% over 7 days, 9.0% over 30 days and 43.0% over the past year, recent moves may be changing how investors think about both its potential and its risks. Recent company updates and industry developments around Syndax's pipeline progress and regulatory milestones...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

Is Improving Analyst Sentiment Reframing Exelixis (EXEL) Oncology Pipeline As A Core Valuation Anchor?

Exelixis recently presented at the TD Cowen 46th Annual Health Care Conference in Boston, reinforcing its oncology focus and partnerships with Ipsen, Takeda, and Roche. Analyst commentary has turned more optimistic, citing Exelixis’s oncology pipeline, strengthened earnings forecasts, and valuation appeal as reasons for growing institutional interest. We’ll now examine how this improving analyst sentiment, supported by higher earnings forecasts, may influence Exelixis’s existing investment...